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Abstract 
Purified cytochrome b-559 reconstituted into liposomes, consisting of certain azolectin-based phospholipid mixtures, is capable of 
NADPH-supported FAD-dependent superoxide (O~-) production in the absence of cytosolic activators. This system, representing the 
simplest model of the respiratory burst NADPH oxidase, was used to study cytochrome b-559 enzymology and distinguish putative 
mechanisms of NADPH oxidase activation (Koshkin, V. and Pick, E. (1993) FEBS Lett. 327, 57-62; (1994) FEBS Lett. 338, 285-289). 
In the present report, representing an extension of our earlier investigations, two types of vesicle-incorporated and reflavinated 
cytochrome b-559 preparation were distinguished by their ability to catalyze vectorial electrogenic or scalar electron transport from 
NADPH to oxygen. This can be explained by the existence of two distinct membranal locations of cytochrome b-559, with 
NADPH-binding and O2-reducing sites exposed on different or on the same side of the membrane. The mode of cytochrome b-559 
insertion into the membrane depended on the reconstitution method employed. Both states of the reconstituted cytochrome b-559 were 
functionally competent judging by their susceptibility to additional activation by cytosolic NADPH oxidase components. The capability of 
flavocytochrome b-559 to function as a transmembrane el ctrogenic electron carrier points to its crucial role in the respiratory burst not 
only in its catalytical but also in its vectorial aspect. The scalar mode of its action may be related to respiratory burst pathology. 
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1. Introduction 
Phagocytic ells respond to a variety of stimulants by 
the production of oxygen radicals, a process known as the 
respiratory burst. The primary oxygen radical, superoxide 
(O~-), is generated by the NADPH-driven one-electron 
reduction of oxygen, catalyzed by a membrane-bound 
NADPH oxidase complex [1-3]. This contains flavin and 
heme electron transport moieties and carries out transmem- 
brane electrogenic electron transport from cytosolic 
NADPH to oxygen in the extracellular or vacuolar space 
[4-7]. For a long time this system was considered as an 
electron transport chain, consisting of an NADPH-binding 
flavoprotein and an O2-reducing cytochrome b-559, which 
is converted from the dormant to the active state by 
Abbreviations: b-559-1iposomes, cytochrome-b-559-containing lipo- 
somes; 02, superoxide; EGTA, [ethylenebis(oxyethylenenitrilo)tetra- 
acetic acid; LIDS, lithium dodecyl sulfate; PMSF phenylmethylsulfonyl 
fluoride; SOD, superoxide dismutase. 
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complexing of the membranal and cytosolic components. 
The recent advances in the understanding of the composi- 
tion and action of this complex are due to its reconstitution 
in vitro in a cell-free system [8,9]. This consists of purified 
and relipidated cytochrome b-559, the cytosolic compo- 
nents p47-phox and p67-phox, the small G protein Racl or 
Rac2 and an anionic amphiphile, serving as activator. 
Studies utilizing this system led to the concept that cy- 
tochrome b-559 represents the only catalytic omponent of 
NADPH-oxidase, bearing, in addition to the oxygen-reduc- 
ing heme group, NADPH- and FAD-binding sites and 
performing the complete catalytic sequence of the respira- 
tory burst upon activation by complexing with cytosolic 
proteins [10-12]. Resting on this concept and on the 
spatial properties of respiratory burst in the intact cell, it 
was supposed that the cytochrome b-559 molecule pro- 
vides an electron route through the cell membrane [11,13], 
although experimental data on its membrane topography 
are very limited [14]. 
We recently provided direct functional proof for the 
catalytic competence of cytochrome b-559 by demonstrat- 
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ing its ability to function as an independent generator of 
O 2 in vitro. [15,16]. Thus, we showed that cytochrome 
b-559, incorporated into phospholipid vesicles of a certain 
composition, is capable of NADPH-driven, FAD-depen- 
dent O~ production i  the absence of the cytosolic ompo- 
nents of NADPH oxidase. This system was found useful to 
study cytochrome b-559 enzymology and the mechanism 
of its activation. The work presented here was undertaken 
with the purpose to determine the spatial orientation of 
cytochrome b-559 in this system. This could provide 
insight into its interaction with the membrane and clear up 
spatial properties of the cell-free model of NADPH oxi- 
dase, which are totally unknown. For this purpose, cy- 
tochrome b-559 was incorporated into phospholipid vesi- 
cles by different methods and its electron transport activity 
with an external electron donor and an internal acceptor 
was studied. It is shown that cytochrome b-559 may insert 
into liposomes in two different modes; their properties are 
described and their possible relation to the native system is 
discussed. 
2. Materials and methods 
2.1. Purification of cytochrome b-559 
Cytochrome b-559 was purified by the previously de- 
scribed method [15,17] with the slight modifications. 
Guinea-pig peritoneal macrophage membranes, prewashed 
with 1 M NaC1, were suspended in 1.5 M NaC1, 200 mM 
sucrose containing 15 mM phosphate buffer (pH 7.0), and 
separated into low-speed (10000 X g, 30 min) and high- 
speed (40 000 X g, 120 min) sedimented fractions. The last 
fraction was used for further purification, which included 
solubilization with 40 mM octyl glucoside in buffer A 
(0.05 M sodium phosphate (pH 7.4), 1 mM MgC12, 1 mM 
EGTA, 0.2 mM dithioerythritol, 1 mM PMSF, 1 /xg/ml 
leupeptin, 20% glycerol), affinity chromatography on hep- 
arin agarose and gel-filtration on Superose 12. The concen- 
tration of cytochrome b-559 was determined from the 
differential reduced-minus-oxidized spectra using the ex- 
tinction coefficient (427-411 nm)= 200 mM-1 cm-1 [18]. 
Protein concentration was measured by the method of 
Bradford [19], with bovine gamma-globulin as the stan- 
dard. Purified cytochrome b-559 (7-9 nmol heme/mg 
protein) was used for electron transport experiments, and 
the partially purified one (1.5-3 nmol heme/mg protein) 
for membrane potential and permeability measurements. 
2.2. Reconstitution of cytochrome b-559 into liposomes 
Reconsitution was accomplished by adaptation of the 
methods described in the literature [20-24]. Mixed phos- 
pholipids of the 'azolectin' type (L-c~-phosphatidylcholine 
type II-S, Sigma) were dispersed under nitrogen with slight 
sonication in buffer A, containing 40 mM octyl glucoside, 
at a concentration of 7 mg/ml. Liposome formation was 
achieved by dialysis for 16-18 h against 200 vol. of 
detergent-free buffer A. Cytochrome b-559-containing li- 
posomes (b-559-1iposomes) were obtained by two meth- 
ods: (a) by co-solubilization of cytochrome b-559 in an 
octyl glucoside-phospholipid mixture with slight sonica- 
tion (Microson cell disruptor, 10% output power, 2 X 5 s) 
and 1-4 h incubation in ice before dialysis; and (b) by 
direct incorporation i to preformed liposomes, i.e., mixing 
cytochrome b-559 with liposome suspension 1:10 (v/v)  
and brief (15-30 min) incubation in ice. Cytochrome 
b-559 binding to phospholipid vesicles was confirmed by 
passing through Sepharose 4B column (1 X 16 cm). b- 
559-1iposomes with internally trapped NADPH or cyto- 
chrome c were prepared by addition of NADPH (1.45 
mM) or cytochrome c (180 /xM) to the starting phospho- 
lipid-protein mixture and, after dialysis, the loaded lipo- 
somes were separated from free solutes on a Sephadex 
G-75 column (1 X 15 cm). These liposomes howed uni- 
modal size distribution in the region of 80-180 nm deter- 
mined by quasi-elastic light scattering using Malvern sys- 
tem 4700 c analyzer. Cytochrome b-559 concentration i  
the cytochrome-c-loaded b-559-1iposomes was estimated 
from the differential spectra of dithionite-reduced minus 
ascorbate-reduced samples using the extinction coefficient 
(559-540 nm)= 21.6 mM -1 cm -1 [25]. 
2.3. Electron transport activity 
This was assayed by the rate of cytochrome c reduction 
[9] or NADPH oxidation [26] in buffer B, consisting of 65 
mM potassium, sodium phosphate buffer (pH 7.0), 1 mM 
MgC12, 1 mM EGTA, with additional ingredients, when 
added, indicated in the text and legends to figures. Mea- 
surements were performed with a Uvikon 860 spectro- 
photometer (Kontron) using a 'time drive' program and 
rate values were obtained using 'derivative overlay' pro- 
gram. 
2.4. Other assays 
Membrane potential generation i  electron-transporting 
b-559-1iposomes was measured with the optical membrane 
potential indicator safranin [27,28] by monitoring an ab- 
sorbance at 530 nm. The initial mixture for b-559-1ipo- 
some preparation was supplemented with SOD (150 U/ml) 
and catalase (233 U/ml)  in order to provide 0 2 scaveng- 
ing on both sides of the membrane. Optical response 
calibration was performed by the conventional K +- 
valinomycin method [27,28] using the Nernst equation 
E = 60 log [K+]in/[K+]ou t for K+-diffusion potential cal- 
culation, where [K+]in and [K+]out denote the potassium 
concentrations inside and outside the vesicles, respectively 
(the cationic composition of the media employed was 
modified to get K+-containing vesicle stock suspension 
and Na+-containing assay medium). 
V. Koshkin / Biochimica et Biophysica Acta 1229 (1995) 329-333 331 
Fluorometric detection of intraliposomal NADPH oxi- 
dation was performed with a FP-770 spectrofluorometer 
(Jasco). 
3. Results and discussion 
Orientation of membrane nzymes can be determined 
by functional assays [24] provided that the membrane 
permeability to related substrates is known. To define 
liposomes permeability to NADPH and 0 2 following two 
systems were used: (a) b-559-1iposomes with internally 
entrapped NADPH and external NADPH oxidant glu- 
tathione + glutathione reductase; and (b) b-559-1iposomes 
with internally entrapped cytochrome c and external 0 2 
generator xanthine + xanthine oxidase. The data given in 
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Fig. 1. Determination of the NADPH and 0 2 permeability of liposomes 
with incorporated cytochrome b-559. (A) Oxidation of intraliposomal 
NADPH by an external glutathione-glutathione reductase system. 1 ml of 
azolectin dispersion (7 mg/ml )  was supplemented with 150 pmol of 
cytochrome b-559 and 1.45 mM of NADPH and treated as described 
under Materials and methods, 200 /.d of final liposome suspension were 
diluted to 0.6 ml with buffer B and fluorescence (excitation 340 nm, 
emission 450 nm) was monitored. At the time indicated by the arrow, 
1.23 mM glutathione and 0.0037 unit of glutathione r ductase were added 
to: (a) the intact system, (b) the system treated with 30 mM octyl 
glucoside, (c) the system treated by freezing-thawing ( -  75-0 ° C), and 
(d) an equivalent amount of free NADPH. (B) Reduction of intraliposo- 
mal cytochrome c by external xanthine-xanthine oxidase system. 1 ml of 
azolectin dispersion (7 mg/ml )  was supplemented with 139 pmol of 
cytochrome b-559 and 180 p,M of cytochrome c and treated as described 
under Material and methods. 100 /xM of final suspension were diluted 
with buffer B to 0.65 ml and absorbance at 550 nm was monitored. At 
times indicated by arrows 50 /zM xanthine and 0.00036 unit xanthine 
oxidase were added to: (a) intact vesicles, (b) intact vesicles + 100 U /ml  
SOD, (c) vesicles treated by freezing-thawing ( -75 -0  ° C), and (d) 
vesicles treated with 30 mM octyl glucoside. 
Fig. 1 illustrate the behavior of these systems in two 
situations: intact liposomes and after their permeabilization 
by freezing-thawing or lysis by detergent. One can see that 
NADPH inside the vesicles is inaccessible to glutathione 
reductase but becomes freely accessible after freezing- 
thawing or detergent addition (Fig. 1A). As regards O 2 
(Fig. 1B), this was found to be able to penetrate through 
the phospholipid membrane (curve a), in agreement with 
an earlier eport [29], although the membrane r presented a 
noticeable diffusion barrier for this ion (curves c,d). Re- 
duction of internal cytochrome c by externally generated 
0 2 was completely inhibited by externally added SOD 
(curve b). Both types of b-559-1iposome possessed similar 
permeability properties. 
Bearing in mind these results, we investigated electron 
transport in cytochrome c-loaded b-559-1iposomes supple- 
mented with external NADPH. Data in Fig. 2A demon- 
strate that reflavinated cytochrome b-559, incorporated 
into cytochrome-c-loaded liposomes by cosolubilization 
with phospholipid, transfers electrons from external 
NADPH to internal cytochrome c with an initial rate 
essentially independent of external SOD (at the same time, 
further cytochrome c reduction revealed also the presence 
of the SOD-sensitive component). The process becomes 
entirely SOD-sensitive after liposome permeabilization by
freezing-thawing (Fig. 2B). Evidently, SOD-resistant cy- 
tochrome c reduction indicates intraliposomal formation of 
02, i.e., it proves that in this system cytochrome b-559 
catalyzes transmembrane electron transfer from external 
NADPH to internal oxygen (the SOD-sensitive component 
apparently reflects reduction of intravesicular cytochrome 
c due to interliposomal 0 2 transfer from other vesicles). 
When cytochrome b-559 was reconstituted into liposomes 
by direct incorporation, NADPH-induced cytochrome c
reduction was completely SOD-sensitive in the intact 
poorly permeable vesicles (Fig. 2C), suggesting that elec- 
tron transfer, in this case, was confined to the outer side of 
the membrane, followed by 0 2 diffusion into the lipo- 
somes. 
For the investigation of the membrane potential forma- 
tion in b-559-1iposomes, SOD and catalase were included 
both inside and outside the vesicles, in order to quench 0 2 
at the site of its formation and prevent its transmembrane 
diffusion. The medium was supplemented with 30 /~M 
LIDS, which is known to accelerate lectron transport in 
this system [15,16]. Fig. 3 illustrates a typical membrane 
potential measurement with the membrane-penetrating 
cationic dye safranin, which undergoes an absorbance shift 
on accumulation i side negatively charged vesicles [27,28]. 
The applicability of this method was confirmed by the 
differential spectrum (Fig. 3, inset) characteristic of accu- 
mulated safranin [27,28] and by the effect of omitting FAD 
(Fig. 3, curves a,b). As apparent in Fig. 3, NADPH-in- 
duced potential formation (negative inside, exceeding 45 
mV from K÷-valinomycin calibration) takes place only 
with b-559-1iposomes prepared by cytochrome-lipid cosol- 
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ubilization (curve a); b-559-1iposome prepared by cy- 
tochrome incorporation, with only slightly lowered elec- 
tron transport activity (5 against 7 e - /heme per s), were 
unable to generate membrane potential (curve c). These 
data on the orientation of cytochrome b-559 in the mem- 
brane agree with those based on the effect of SOD and 
suggest that cytochrome b-559 can be incorporated into 
membranes in two manners, which are similar in their 
catalytic activity but differ in vectorial and electrogenic 
properties. Both variants of relipidated cytochrome b-559 
being placed into a conventional cell-free system [9,15] 
could be further activated by cytosol with turnover rate 
rising from 5-10  to 50-60 mol O2/mol  cytochrome 
b-559 per s (these values should be considered as minimal 
because of the possibility that some fraction of cytochrome 
b-559 is inactive due to the inside-oriented NADPH-bind- 
ing site). This confirms the complete functional compe- 
tence of both membrane-bound forms of cytochrome b-559. 
The data presented emonstrate the existence of two 
states of membrane-incorporated flavocytochrome b-559: 
(a) with a transmembranal topography of electron input 
and output sites, and (b) with both sites exposed on the 
same side of the membrane. They catalyse, respectively, 
vectorial electrogenic and scalar electron transfer from 
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Fig. 2. Determination f spatial orientation ofcytochrome b-559 incorpo- 
rated into liposomes. (A) Electron transport in the intact cytochrome 
c-loaded b-559-1iposomes, prepared by cytochrome b-559-phospholipid 
co-solubilization. 100 /zl of b-559-1iposomes, prepared as described in 
the legend to Fig. 1B, were diluted with buffer B to 0.65 ml, supple- 
mented with 0.73 /zM FAD and NADPH-driven cytochrome c reduction 
was monitored in the absence (a) or presence (b) of 100 U/ml SOD 
(saturating amount). Arrows marked 1 indicate the addition of 0.43 mM 
of NADPH, dithionite reduction is pointed by arrows marked 2. (B) 
Electron transport inthe same liposomes, treated by freezing-thawing. (C) 
Electron transport in the intact cytochrome c-loaded b-559-1iposomes, 
prepared by the direct incorporation f cytochrome b-559. 
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Fig. 3. Membrane potential formation in the course of the electron 
transport in b-559-1iposomes. 100/xl of b-559-1iposomes, prepared by 
cytochrome b-559 co-solubilization (curves a,b) or direct incorporation 
(curve c) as decribed under Materials and methods were diluted with 
buffer B to 0.65 ml and supplemented with 7.4 /*M safranin, 30 /zM 
LiDS and 0.73 /.LM FAD (curves a,c). The reaction was started by the 
addition of 0.22 mM NADPH indicated by arrow marked 1 and ab- 
sorbance at 530 nm was monitored (dilution effects were corrected by 
subtracting the signal change induced by addition of an equal volume of 
buffer B). The dotted line represent calibrating marks obtained after 
addition of 0.1 /xM valinomycin (arrow marked 2) to the b-559-1ipo- 
somes prepared inK+-containing medium and placed into K +- (curved ) 
or Na ÷- (curve e) containing buffer B. In the inset is shown the 
differential spectrum (after minus before NADPH addition) of the lipo- 
some suspension, curve a. 
NADPH to oxygen. Apparently, the first state underlies the 
physiological transmembranal operation of the respiratory 
burst oxidase, whereas the second one suggests the possi- 
bility of its functioning on the one side of the membrane, 
which could be of interest from the standpoint of respira- 
tory burst pathology. On the other hand, though a number 
of recent data prove the ability of cytochrome b-559 to 
perform NADPH-supported FAD-dependent 0 2 reduction 
[10-12,15,16], some findings suggest hat it can interact 
with other flavoproteins [30-32], including one located in 
the neutrophil membrane [33,34], and the possibility of 
cytochrome b-559 cooperating with additional electron 
transferring component in vivo still cannot be completely 
ruled out. In the light of this, it is of interest hat relipi- 
dated and reflavinated cytochrome b-559 provides the 
basis not only for the catalytical, but also for the vectorial 
and electrogenic functions of the native NADPH oxidase. 
Finally, it should be mentioned that the presence of diffu- 
sion barriers in cytochrome b-559-containing l iposomes 
may lead to underestimation f NADPH oxidase turnover 
rates measured in the cell-free system. 
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